Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. ((2r)-3-(4-butoxycarbonylpiperazin-1-yl)-2-((6-((3s)-3-methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl)amino)-3-oxopropyl)phosphonic Acid
2. Act-246475
1. Selatogrel [inn]
2. 6dpk7o4pr7
3. Act-246475
4. 4-((r)-2-((6-((s)-3-methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl)amino)-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester
5. 1159500-34-1
6. 1-piperazinecarboxylic Acid, 4-((2r)-2-(((6-((3s)-3-methoxy-1-pyrrolidinyl)-2-phenyl-4-pyrimidinyl)carbonyl)amino)-1-oxo-3-phosphonopropyl)-, 1-butyl Ester
7. Unii-6dpk7o4pr7
8. Schembl2928412
9. Chembl4297589
10. Db15163
11. J3.559.357h
12. ((2r)-3-(4-butoxycarbonylpiperazin-1-yl)-2-((6-((3s)-3-methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl)amino)-3-oxopropyl)phosphonic Acid
13. [(2~{r})-3-(4-butoxycarbonylpiperazin-1-yl)-2-[[6-[(3~{s})-3-methoxypyrrolidin-1-yl]-2-phenyl-pyrimidin-4-yl]carbonylamino]-3-oxidanylidene-propyl]phosphonic Acid; [(2r)-3-(4-butoxycarbonylpiperazin-1-yl)-2-[[6-[(3s)-3-methoxypyrrolidin-1-yl]-2-phenyl-pyrimidin-4-yl]carbonylamino]-3-oxidanylidene-propyl]phosphonic Acid; 4-((r)-2-((6-((s)-3-methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl)amino)-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester
14. 7y5
| Molecular Weight | 618.6 g/mol |
|---|---|
| Molecular Formula | C28H39N6O8P |
| XLogP3 | 0.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 12 |
| Exact Mass | 618.25669922 g/mol |
| Monoisotopic Mass | 618.25669922 g/mol |
| Topological Polar Surface Area | 175 Ų |
| Heavy Atom Count | 43 |
| Formal Charge | 0 |
| Complexity | 986 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of acute myocardial infarction
ABOUT THIS PAGE
A Selatogrel manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Selatogrel, including repackagers and relabelers. The FDA regulates Selatogrel manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Selatogrel API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Selatogrel supplier is an individual or a company that provides Selatogrel active pharmaceutical ingredient (API) or Selatogrel finished formulations upon request. The Selatogrel suppliers may include Selatogrel API manufacturers, exporters, distributors and traders.
Selatogrel Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Selatogrel GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Selatogrel GMP manufacturer or Selatogrel GMP API supplier for your needs.
A Selatogrel CoA (Certificate of Analysis) is a formal document that attests to Selatogrel's compliance with Selatogrel specifications and serves as a tool for batch-level quality control.
Selatogrel CoA mostly includes findings from lab analyses of a specific batch. For each Selatogrel CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Selatogrel may be tested according to a variety of international standards, such as European Pharmacopoeia (Selatogrel EP), Selatogrel JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Selatogrel USP).
LOOKING FOR A SUPPLIER?
